Form 8-K - Current report:
SEC Accession No. 0001104659-10-012274
Filing Date
2010-03-05
Accepted
2010-03-05 09:20:32
Documents
1
Period of Report
2010-03-01
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K a10-5221_18k.htm 8-K 20643
  Complete submission text file 0001104659-10-012274.txt   22324
Mailing Address 420 LEXINGTON AVENUE SUITE 1609 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 1609 NEW YORK NY 10170 212-297-0010
SYNERGY PHARMACEUTICALS, INC. (Filer) CIK: 0001347613 (see all company filings)

EIN.: 203823853 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 333-131722 | Film No.: 10659134
SIC: 2834 Pharmaceutical Preparations